Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability.

Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability.

Item
http://www.wikidata.org/entity/Q34117426
Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer.Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1)Prognostic role of YB-1 expression in breast cancer: a meta-analysisImpact of oncogenic K-RAS on YB-1 phosphorylation induced by ionizing radiation.Y-Box Binding Protein 1 Stabilizes Hepatitis C Virus NS5A via Phosphorylation-Mediated Interaction with NS5A To Regulate Viral Propagation.Targeted therapy for breast cancer prevention.Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models.Targeting ribosomal S6 kinases/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancer.Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancers.YB-1 expression promotes epithelial-to-mesenchymal transition in prostate cancer that is inhibited by a small molecule fisetin.Role of Y Box Protein-1 in cancer: As potential biomarker and novel therapeutic target.Trilayer micelles for combination delivery of rapamycin and siRNA targeting Y-box binding protein-1 (siYB-1).GOLPH3 and YB-1 Are Novel Markers Correlating With Poor Prognosis in Prostate Cancer.The promise and challenges of targeting RSK for the treatment of cancer.Disrupting Y-Box-Binding Protein 1 Function Using OSU-03012 Prevents Endometriosis Progression in In Vitro and In Vivo Models.Fisetin targets YB-1/RSK axis independent of its effect on ERK signaling: insights from in vitro and in vivo melanoma models
P2860

Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability.

Item
http://www.wikidata.org/entity/Q34117426
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Molecular decoy to the Y-box b ...... sparing normal cell viability.
@ast
Molecular decoy to the Y-box b ...... sparing normal cell viability.
@en
Molecular decoy to the Y-box b ...... sparing normal cell viability.
@nl
type
label
Molecular decoy to the Y-box b ...... sparing normal cell viability.
@ast
Molecular decoy to the Y-box b ...... sparing normal cell viability.
@en
Molecular decoy to the Y-box b ...... sparing normal cell viability.
@nl
prefLabel
Molecular decoy to the Y-box b ...... sparing normal cell viability.
@ast
Molecular decoy to the Y-box b ...... sparing normal cell viability.
@en
Molecular decoy to the Y-box b ...... sparing normal cell viability.
@nl
P1433
P1476
P2093
P2860
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Molecular decoy to the Y-box b ...... sparing normal cell viability.
@en
P2093
P2860
P31
P356
10.1371/JOURNAL.PONE.0012661
P407
P433
P478
P577
P5875
P698
P932